Evidence map›Paper›PMID 41770565›Full record

ArticleJAMA network open2026

Collecting Social Determinants of Health in a Children's Oncology Group Trial for High-Risk Neuroblastoma.

Emily Jones, Arlene Naranjo, Lena E Winestone, Puja J Umaretiya, Rahela Aziz-Bose, Colleen A Kelly, Haley Newman, Daniel J Zheng, Emily Greengard, Rochelle Bagatell and 2 more

Abstract read
In one paragraph

Article in JAMA network open, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Emily JonesDana-Farber Boston Children's Cancer and Blood Disorders Center, Boston, Massachusetts.
Arlene NaranjoChildren's Oncology Group Statistics and Data Center, University of Florida, Gainesville.
Lena E WinestoneUCSF Benioff Children's Hospital, San Francisco, California.
Puja J UmaretiyaDepartment of Pediatrics, University of Texas Southwestern Medical Center, Dallas.
Rahela Aziz-BoseDana-Farber Boston Children's Cancer and Blood Disorders Center, Boston, Massachusetts.
Colleen A KellyDana-Farber Boston Children's Cancer and Blood Disorders Center, Boston, Massachusetts.
Haley NewmanDivision of Oncology, Department of Pediatrics, Children's Hospital of Philadelphia and Perelman School of Medicine, Philadelphia, Pennsylvania.
Daniel J ZhengDivision of Oncology, Department of Pediatrics, Children's Hospital of Philadelphia and Perelman School of Medicine, Philadelphia, Pennsylvania.
Emily GreengardChildren's Minnesota, Minneapolis.
Rochelle BagatellDivision of Oncology, Department of Pediatrics, Children's Hospital of Philadelphia and Perelman School of Medicine, Philadelphia, Pennsylvania.
Steven G DuBoisDana-Farber Boston Children's Cancer and Blood Disorders Center, Boston, Massachusetts.
Kira BonaDana-Farber Boston Children's Cancer and Blood Disorders Center, Boston, Massachusetts.

Funding

NCTN BIQSFP ANBL1531 (NRT)U10CA180886 · NCI · PUBLIC HEALTH INSTITUTE · PI Douglas S. Hawkins · 2014 to 2026
$390.6M
COG SDMC - Statistics CoreU10CA180899 · NCI · UNIVERSITY OF SOUTHERN CALIFORNIA · PI TODD A ALONZO · 2014 to 2026
$132.8M
NCI NIH HHS U10 CA180886NCI NIH HHS U10 CA180899
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID41770565
PMCPMC12954535

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.